hillevax.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.hillevax.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Hillevax - Advancing a Vaccine to Protect Against |
| Description | Advancing the development of a vaccine to protect against norovirus infection, the most common Advancing the development of a vaccine to protect against norovirus infection, the most common viral cause of acute gastroenteritis |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 23.185.0.1 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
hillevax.com Valuation
|
US$10,554,855
Last updated: 2023-05-10 01:41:44
hillevax.com has Semrush global rank of 1,002,790. hillevax.com has an estimated worth of US$ 10,554,855, based on its estimated Ads revenue. hillevax.com receives approximately 1,217,868 unique visitors each day. Its web server is located in -, with IP address 23.185.0.1. According to SiteAdvisor, hillevax.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$10,554,855 |
| Daily Ads Revenue | US$9,743 |
| Monthly Ads Revenue | US$292,289 |
| Yearly Ads Revenue | US$3,507,460 |
| Daily Unique Visitors | 81,192 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| hillevax.com. | A | 599 | IP: 23.185.0.1 |
| hillevax.com. | AAAA | 599 | IPV6: 2620:12a:8000::1 |
| hillevax.com. | AAAA | 599 | IPV6: 2620:12a:8001::1 |
| hillevax.com. | NS | 3600 | NS Record: ns56.domaincontrol.com. |
| hillevax.com. | NS | 3600 | NS Record: ns55.domaincontrol.com. |
| hillevax.com. | MX | 3600 | MX Record: 0 hillevax-com.mail.protection.outlook.com. |
| hillevax.com. | TXT | 600 | TXT Record: google-site-verification=qDSYEwz_s1YitUodo4vq6EZAlLRlq--yexT-HslPuKQ |
| hillevax.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| hillevax.com. | TXT | 600 | TXT Record: MS=ms41620066 |
HtmlToTextCheckTime:2023-05-10 01:41:44
| Skip to Main Content Menu Button About Us Management Board of Directors Pipeline Careers Open Positions Benefits Core Values Life At Hillevax Investors and Media Overview News & Events Stock Information Corporate Governance Financial Information IR Resources Contact Us Advancing the development of a vaccine to protect against norovirus infection, the most common viral cause of acute gastroenteritis worldwide Norovirus Key Statistics 90 % Norovirus is responsible for greater than 90% of epidemic non-bacterial outbreaks of gastroenteritis. [1, 2] 700 M+ Norovirus is estimated to cause approximately 700 million cases of gastroenteritis and 200,000 deaths worldwide annually. [3] $ 60 B+ The global economic burden of norovirus is estimated to be $60.3 billion annually . [3] Website built by: 3 Media Web Solutions, Inc. ©2023 HilleVax, Inc. All rights reserved. Discover About Us Investors Pipeline Careers Contact Us Contact 75 State St, Suite 100 Boston, MA 02109 (888) 340-4544 (617) |
HTTP Headers
HTTP/1.1 301 Moved Permanently Retry-After: 0 Content-Length: 0 Server: Pantheon Location: https://www.hillevax.com/ X-Pantheon-Redirect: primary-domain-policy-doc Date: Mon, 01 Nov 2021 22:14:57 GMT Connection: close X-Served-By: cache-chi21155-CHI X-Cache: HIT X-Cache-Hits: 0 X-Timer: S1635804898.563174,VS0,VE3 Age: 0 Accept-Ranges: bytes Via: 1.1 varnish HTTP/2 200 content-type: text/html etag: W/"617c3f91-27b4" last-modified: Fri, 29 Oct 2021 18:38:09 GMT server: nginx strict-transport-security: max-age=300 x-pantheon-styx-hostname: styx-fe1-a-bcfddf949-27tbq x-styx-req-id: 25f6e69e-3b61-11ec-953c-6e45f69c9b1f date: Mon, 01 Nov 2021 22:14:57 GMT x-served-by: cache-mdw17346-MDW, cache-stl4838-STL x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1635804898.626441,VS0,VE40 vary: Accept-Encoding, Cookie, Cookie age: 0 accept-ranges: bytes via: 1.1 varnish, 1.1 varnish content-length: 10164 |
hillevax.com Whois Information
Domain Name: HILLEVAX.COM Registry Domain ID: 2582732549_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-05T01:05:51Z Creation Date: 2021-01-05T01:05:50Z Registry Expiry Date: 2022-01-05T01:05:50Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS55.DOMAINCONTROL.COM Name Server: NS56.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T06:41:15Z <<< |